Escolar Documentos
Profissional Documentos
Cultura Documentos
REFERÊNCIAS BIBLIOGRÁFICAS
1. Associated Press. FDA approves use of pad in breast exam. New York Times,
December 25, 1995, p. 9Y.
3. Baines, C. J., and Dayan, R. A tangled web: Factors likely to affect the efficacy of
screening mammography. J. Natl. Cancer Inst. 91( 10): 833- 838, 1999.
4. Baines, C. J., Miller, A. B., and Bassett, A. A. Physical examination: Its role as a single
screening modality in the Canadian National Breast Screening Study. Cancer 63: 1816-
1822, 1989.
6. Bertell, R. Breast cancer and mammography. Mothering, Summer 1992, pp. 49- 52.
7. Black WC, Welch HG: Advances in diagnostic imaging and overestimations of disease
prevalence and the benefits of therapy. N Engl J Med 328 (17): 1237-43, 1993. [PUBMED
Abstract]
9. Brewer NT, Salz T, Lillie SE: Systematic review: the long-term effects of false-positive
mammograms. Ann Intern Med 146 (7): 502-10, 2007. [PUBMED Abstract]
10. Bridges, B. A., and Arlett, C. F. Risk of breast cancer in ataxia-telangiectasia. N. Engl.
J. Med. 326( 20): 1357, 1992.
11. Buist DSM, Porter P L, Lehman C, Taplin SH, White E. Factors Contributing to
Mammography Failure in Women Aged 40–49 Years. Journal of the National Cancer
Institute, Vol. 96, No. 19, October 6, 2004
12. Burman ML, Taplin SH, Herta DF, et al.: Effect of false-positive mammograms on
interval breast cancer screening in a health maintenance organization. Ann Intern Med 131
(1): 1-6, 1999. [PUBMED Abstract]
13. Christiansen CL, Wang F, Barton MB, et al.: Predicting the cumulative risk of false-
positive mammograms. J Natl Cancer Inst 92 (20): 1657-66, 2000. [PUBMED Abstract]
14. Davis, D. L., and Love, S. J. Mammography screening. JAMA 271( 2): 152- 153, 1994.
15. Duffy SW, Lynge E, Jonsson H, et al.: Complexities in the estimation of overdiagnosis
in breast cancer screening. Br J Cancer 99 (7): 1176-8, 2008. [PUBMED Abstract]
16. Elmore JG, Barton MB, Moceri VM, et al.: Ten-year risk of false positive screening
mammograms and clinical breast examinations. N Engl J Med 338 (16): 1089-96, 1998.
[PUBMED Abstract]
17. Epstein, S. S. American Cancer Society: The world’s wealthiest «non-profit» institution.
Int. J. Health Serv. 29(3): 565-578, 1999.
18. Epstein, S. S., and Gross, L. The high stakes of cancer prevention. Tikkun 15( 6): 33-
39, 2000.
19. Epstein, S. S., Steinman, D., and LeVert, S. The Breast Cancer Prevention Program,
Ed. 2. Macmillan, New York, 1998.
20. Feig SA, Ehrlich SM: Estimation of radiation risk from screening mammography: recent
trends and comparison with expected benefits. Radiology 174 (3 Pt 1): 638-47, 1990.
[PUBMED Abstract]
21. Feuer EJ, Wun LM: How much of the recent rise in breast cancer incidence can be
explained by increases in mammography utilization? A dynamic population model
approach. Am J Epidemiol 136 (12): 1423-36, 1992. [PUBMED Abstract]
22. Freitas R 2nd, Fiori WF, Ramos FJ, et al.: [Discomfort and pain during mammography].
Rev Assoc Med Bras 52 (5): 333-6, 2006 Sep-Oct. [PUBMED Abstract]
23. Gehrke, A. Breast self-examination: A mixed message. J. Natl. Cancer Inst. 92( 14):
1120- 1121, 2000.
24. Gofman, J. W. Preventing Breast Cancer: The Story of a Major Proven Preventable
Cause of this Disease. Committee for Nuclear Responsibility, San Francisco, 1995.
25. Gøtzsche PC, Jørgensen KJ, Maehlen J, et al.: Estimation of lead time and
overdiagnosis in breast cancer screening. Br J Cancer 100 (1): 219; author reply 220,
2009. [PUBMED Abstract]
26. Gøtzsche PC, Nielsen M: Screening for breast cancer with mammography. Cochrane
Database Syst Rev (4): CD001877, 2006. [PUBMED Abstract]
28. Gotzsche, P. C., and Olsen, O. Is screening for breast cancer with mammography
justifiable? Lancet 355: 129- 134, 2000.
29. Gram IT, Lund E, Slenker SE: Quality of life following a false positive mammogram. Br
J Cancer 62 (6): 1018-22, 1990. [PUBMED Abstract]
30. Greenlee, R. T. Cancer Statistics, 2001. CA Cancer J. Clin. 51( 1): 15- 36, 2001.
31. Hall, D. C., et al. Improved detection of human breast lesions following experimental
training. Cancer 46( 2): 408- 414, 1980.
32. Helzlsouer KJ, Harris EL, Parshad R, et al.: Familial clustering of breast cancer:
possible interaction between DNA repair proficiency and radiation exposure in the
development of breast cancer. Int J Cancer 64 (1): 14-7, 1995. [PUBMED Abstract]
34. John, L. Digital imaging: A marketing triumph. Breast Cancer Action Newsletter, No. 62,
November-December 2000.
35. Johnson A, Shekhdar J: Breast cancer incidence: what do the figures mean? J Eval
Clin Pract 11 (1): 27-31, 2005. [PUBMED Abstract]
38. Kopans DB: Mammography and radiation risk. In: Janower ML, Linton OW, eds.:
Radiation Risk: a Primer. Reston, Va: American College of Radiology, 1996, pp 21-22.
39. Kuroishi, T., et al. Effectiveness of mass screening for breast cancer in Japan. Breast
Cancer 7( 1): 1- 8, 2000.
40. Laya, M. B. Effect of estrogen replacement therapy on the specificity and sensitivity of
screening mammography. J. Natl. Cancer Inst. 88( 10): 643- 649, 1996.
41. Leight, S. B., et al. The effect of structured training on breast self-examination search
behaviors as measured using biomedical instrumentation. Nurs. Res. 49( 5): 283- 289,
2000.
42. Lerman C, Trock B, Rimer BK, et al.: Psychological side effects of breast cancer
screening. Health Psychol 10 (4): 259-67, 1991. [PUBMED Abstract]
43. Lerner, B. H. Public health then and now: Great expectations: Historical perspectives
on genetic breast cancer testing. Am. J. Public Health 89( 6): 938- 944, 1999.
44. Lewis, T. Women’s health is no longer a man’s world. New York Times, February 7,
2001, p. 1.
45. Miller, A. B. The role of screening in the fight against breast cancer. World Health
Forum 13: 277- 285, 1992.
46. Miller, A. B., Baines, C. J., and Wall, C. Correspondence. J. Natl. Cancer Inst. 93( 5):
396, 2001.
47. Miller, A. B., et al. Canadian National Breast Screening Study-2: 13-year results of a
randomized trial in women aged 50- 59 years. J. Natl. Cancer Inst. 92( 18): 1490- 1499,
2000.
48. Mittra, I. Breast screening: The case for physical examination without mammography.
Lancet 343( 8893): 342- 344, 1994.
49. Napoli, M. Overdiagnosis and overtreatment: The hidden pitfalls of cancer screening.
Am. J. Nurs., 2001.
50. Napoli, M. What do women want to know. J. Natl. Cancer Inst. Monogr. 22: 11- 13,
1997.
54. Pisano ED, Earp J, Schell M, et al.: Screening behavior of women after a false-positive
mammogram. Radiology 208 (1): 245-9, 1998. [PUBMED Abstract]
55. Quigley, D. T. Some neglected points in the pathology of breast cancer, and treatment
of breast cancer. Radiology, May 1928, pp. 338- 346.
56. Rosen EL, Baker JA, Soo MS: Malignant lesions initially subjected to short-term
mammographic follow-up. Radiology 223 (1): 221-8, 2002. [PUBMED Abstract]
57. Ross, W. S. Crusade: The Official History of the American Cancer Society, p. 96. Arbor
House, New York, 1987.
58. Site do INH – National Institutes of Health – USA, breast cancer screening, atualizado
em maio 2013.
59. Skrabanek, P. Shadows over screening mammography. Clin. Radiol. 40: 4- 5, 1989.
60. Smigel, K. Perception of risk heightens stress of breast cancer. J. Natl. Cancer Inst.
85( 7): 525- 526, 1993.
61. Stoutjesdijk MJ, Boetes C, Jager GJ, Beex L, Bult P, Hendriks JH, et al. Magnetic
resonance imaging and mammography in women with a hereditary risk of breast cancer. J
Natl Cancer Inst 2001;93:1095–102.
62. Suleiman OH, Spelic DC, McCrohan JL, et al.: Mammography in the 1990s: the United
States and Canada. Radiology 210 (2): 345-51, 1999. [PUBMED Abstract]
63. Swift M, Morrell D, Massey RB, et al.: Incidence of cancer in 161 families affected by
ataxia-telangiectasia. N Engl J Med 325 (26): 1831-6, 1991. [PUBMED Abstract]
64. Swift, M. Ionizing radiation, breast cancer, and ataxia-telangiectasia. J. Natl. Cancer
Inst. 86( 21): 1571- 1572, 1994.
65. Tarkan, L. An update that matters? Mammography’s next step is assessed. New York
Times, January 2, 2001, p. D5.
67. Vogel, V. G. Screening younger women at risk for breast cancer. J. Natl. Cancer Inst.
Monogr. 16: 55- 60, 1994.
68. Watmough, D. J., and Quan, K. M. X-ray mammography and breast compression.
Lancet 340: 122, 1992.
69. Welch HG, Black WC: Using autopsy series to estimate the disease “reservoir” for
ductal carcinoma in situ of the breast: how much more breast cancer can we find? Ann
Intern Med 127 (11): 1023-8, 1997. [PUBMED Abstract]
70. Welch HG, Fisher ES: Diagnostic testing following screening mammography in the
elderly. J Natl Cancer Inst 90 (18): 1389-92, 1998. [PUBMED Abstract]
72. White E, Lee CY, Kristal AR: Evaluation of the increase in breast cancer incidence in
relation to mammography use. J Natl Cancer Inst 82 (19): 1546-52, 1990. [PUBMED
Abstract]
73. Worden, J. K., et al. A community-wide program in breast self-examination. Prev. Med.
19: 254- 269, 1990.
75. Zahl PH, Strand BH, Maehlen J: Incidence of breast cancer in Norway and Sweden
during introduction of nationwide screening: prospective cohort study. BMJ 328 (7445):
921-4, 2004. [PUBMED Abstract]